陈云

作者:金飞     日期:2021-10-26   点击数:2508  

师资介绍


陈云,女,汉族,198710月生,讲师,博士研究生

研究方向:心血管药理

科研成果

代表性论文:

  1. Yun Chen#(陈云,共同第一作者), Yuyun Hua#, Yuyun Hua, Yue Ding , Guoliang Meng, Wei Zhang. RIPK3-Mediated Necroptosis in Diabetic Cardiomyopathy Requires CaMKII Activation. Oxid Med Cell Longev. 2021; 2021: 6617816.

  2. Yuyun Hua#, Yue Zhang#, Weiwei Gong, Yue Ding, Jieru Shen, Hua Li, Yun Chen*(陈云,共同通讯作者), Guoliang Meng*. Dihydromyricetin improves endothelial dysfunction in diabetic mice via oxidative stress inhibition in a SIRT3-dependent manner. Int J Mol Sci. 2020; 21(18): 6699.

  3. Yun Chen#(陈云,共同第一作者), Yuyun Hua#, Xinshuai Li, Ishfaq Muhammad Arslan, Wei Zhang, Guoliang Meng*. Distinct types of cell death and the implication in diabetic cardiomyopathy. Front Pharmacol.2020; 11: 42. 

  4. Luo H#, Song S#, Yun Chen#(陈云,共同第一作者), Xu M, Sun L, Meng G*, Zhang W*. Inhibitor 1 of protein phosphatase 1 regulates Ca2+/calmodulin- dependent protein kinase II to alleviate oxidative stress in hypoxia- reoxygenation injury of cardiomyocytes. Oxid Med Cell Longev. 2019; 2019: 2193019.

  5. Linlin Sun#, Yun Chen#(陈云,共同第一作者), Huiqin Luo, Mengting Xu, Guoliang Meng*, Wei Zhang*. Ca2+/calmodulin-dependent protein kinase II regulation by inhibitor 1 of protein phosphatase 1 alleviates necroptosis in high glucose-induced cardiomyocytes injury. Biochem Pharmacol. 2019; 163: 194-205.

  6. Yu J#, Chen Y#(陈云,共同第一作者), Xu M, Sun L, Luo H, Bao X, Meng G*, Zhang W*. Ca2+/calmodulin-dependent protein kinase II regulation by inhibitor 1 of protein phosphatase 1 protects against myocardial ischemia reperfusion injury. J Cardiovasc Pharmacol Ther. 2019; 24(5): 460-473.

  7. Jingyao Zhang#Yun Chen #(陈云,共同第一作者), Huiqin Luo, Linlin Sun, Mengting Xu , Jin Yu, Qigang Zhou , Guoliang Meng*, Shengju Yang*. Recent update on the pharmacological effects and mechanisms of dihydromyricetin. Front Pharmacol. 2018; 9:1204.

  8. Zhang J#, Yu J#, Yun Chen #(陈云,共同第一作者), Liu L, Xu M, Sun L, Luo H, Wang Y, Meng G*. Exogenous hydrogen sulfide supplement attenuates isoproterenol-induced myocardial hypertrophy in a sirtuin 3-dependent manner. Oxid Med Cell Longev. 2018; 2018: 9396089.

  9. Yun Chen#(陈云,共同第一作者), Huiqin Luo#, Linlin Sun#, Mengting Xu, Jin Yu, Lulu Liu, Jinyao Zhang, Yuqin Wang, Hongxia Wang, Xiaofeng Bao, Guoliang Meng*. Dihydromyricetin attenuates myocardial hypertrophy induced by transverse aortic constriction via oxidative stress inhibition and SIRT3 pathway enhancement. Int J Mol Sci. 2018; 19(9): 2592.